Return to home page
Searching: Otterbein library catalog
In response to the COVID-19 outbreak, statewide lending via OhioLINK and SearchOhio has been suspended. OPAL member libraries have closed or are operating at reduced service levels. Please contact your library with specific lending requests or if you need assistance.
  Previous Record Previous Item Next Item Next Record
  Reviews, Summaries, etc...
Title Structure-based drug design / edited by Pandi Veerapandian.
Imprint New York : Marcel Dekker, [1997]

View online
View online
Subject Drugs -- Design.
Drugs -- Structure-activity relationships.
Drugs -- Conformation.
Drug Design.
Structure-Activity Relationship.
Alt Name Veerapandian, Pandi.
NetLibrary, Inc.
Description xiii, 647 pages : illustrations ; 24 cm
polychrome rdacc
Bibliography Note Includes bibliographical references (p. 620-634) and index.
Reproduction Electronic reproduction. Boulder, Colo. : NetLibrary, 2000. Available via the World Wide Web. Available in multiple electronic file formats. Access may be limited to NetLibrary affiliated libraries.
ISBN 0585157448 (electronic bk.) : $195.00
0824798694 (hardcover : alk. paper)
OCLC # 44954983
Additional Format Original (DLC) 97020396 (OCoLC)36884865.
Table of Contents
1Inhibitors of HIV-1 Protease / Krzysztof Appelt1
2Structural Studies of HIV-1 Reverse Transcriptase and Implications for Drug Design / Jianping Ding, Kalyan Das, Prem N. S. Yadav [et al.]41
3Retroviral Integrase: Structure as a Foundation for Drug Design / Alison B. Hickman, Fred Dyda83
4Bradykinin Receptor Antagonists / Donald J. Kyle119
5Design of Purine Nucleoside Phosphorylase Inhibitors / Y. Sudhakara Babu, John A. Montgomery, Charles E. Bugg [et al.]151
6Structural Implications in the Design of Matrix-Metalloproteinase Inhibitors / John C. Spurlino171
7Structure-Function Relationships in Hydroxysteroid Dehydrogenases / Igor Tsigelny, Michael E. Baker191
8Design of ATP Competitive Specific Inhibitors of Protein Kinases Using Template Modeling / Janusz M. Sowadski, Charles A. Ellis, Rolf Karlsson [et al.]213
9Structural Studies of Aldose Reductase Inhibition / David K. Wilson, J. Mark Petrash, Florante A. Quiocho229
10Structure-Based Design of Thrombin Inhibitors / Patricia C. Weber, Michael Czarniecki247
11Design of Antithrombotic Agents Directed at Factor Xa / William C. Ripka265
12Polypeptide Modulators of Sodium Channel Function as a Basis for the Development of Novel Cardiac Stimulants / Raymond S. Norton295
13Rational Design of Renin Inhibitors / V. Dhanaraj, J. B. Cooper321
14Structural Aspects in the Inhibitor Design of Catechol O-Methyltransferase / Jukka Vidgren, Martti Ovaska343
15Antitrypanosomiasis Drug Development Based on Structures of Glycolytic Enzymes / Christopher L. M. J. Verlinde, Hidong Kim, Bradley E. Bernstein [et al.]365
16Progress in the Design of Immunomodulators Based on the Structure of Interleukin-1 / Glen Spraggon, Pandi Veerapandian395
17Structure and Functional Studies of Interferon: A Solid Foundation for Rational Drug Design / Michael A. Jarpe, Carol H. Pontzer, Brian E. Szente [et al.]435
18The Design of Anti-Influenza Virus Drugs from the X-Ray Molecular Structure of Influenza Virus Neuraminidase / Joseph N. Varghese459
19Rhinoviral Capsid-Binding Inhibitors: Structural Basis for Understanding Rhinoviral Biology and for Drug Design / Vincent L. Giranda, Guy D. Diana487
20The Integration of Structure-Based Design and Directed Combinatorial Chemistry for New Pharmaceutical Discovery / Roger Bone, F. Raymond Salemme525
21Structure-Based Combinatorial Ligand Design / Amedeo Caflisch, Claus Ehrhardt541
22Peptidomimetic and Neopeptide Drug Discovery: Impact on Structure-Based Drug Design / Tomi K. Sawyer559

If you experience difficulty accessing or navigating this content, please contact the OPAL Support Team